Fondazione Arianna Anticoagulazione
- Address
- Via Paolo Fabbri 1/3
Sponsor Overview
Specializations
Venous thromboembolism recurrence prevention
The sponsor’s clinical research is centered on preventing recurrence after a first episode of venous thromboembolism, with attention to patients who have experienced deep vein thrombosis or pulmonary embolism.
- Secondary prevention after first VTE
- Deep vein thrombosis
- Pulmonary embolism
The therapeutic interest is focused on reducing the risk of relapse in this cardiovascular and thromboembolic setting.
Elderly patient care
Current research activity is directed toward older adults, especially patients around 75 years of age who have had a recent thrombotic event and require strategies tailored to age-related clinical vulnerability.
- Older adults
- Age-related thrombosis risk
- Post-event prevention
This area reflects a specific interest in geriatric thrombosis management and recurrence prevention in a high-risk population.
Antithrombotic therapy evaluation
The sponsor funds research on an antithrombotic treatment approach aimed at lowering relapse risk while maintaining an acceptable safety profile in patients with prior venous thromboembolism.
- Antithrombotic therapy
- Bleeding safety
- Recurrence reduction
Clinical interest extends to balancing protection from recurrent thrombosis with the risk of major bleeding.
Thrombosis and vascular medicine
Its research landscape is embedded in vascular medicine, with emphasis on disorders of clot formation and the prevention of subsequent thrombotic events after an initial diagnosis.
- Thrombosis
- Vascular disease
- Clot recurrence
The funded trial activity aligns with clinical questions in hemostasis and long-term management after venous clotting events.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of Sulodexide for the Prevention of Recurrent Venous Thromboembolism in Elderly Patients Post-First Episode of Deep Vein Thrombosis or Pulmonary Embolism |  Italy | Not Yet Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 1 is not being studied by other sponsors.
This sponsor has worked with 27 sites across their trial portfolio.
Therapeutic Focus
- 1.Cardiovascular Diseases1 trial359 other sponsors
Partnered Research Centres
27 centres- Address
- Via Dell' Eremo 9, 23900 Lecco
- Address
- via Conca 71, 60126 Torrette (AN), Ancona
- Address
- VIALE TRE MARTIRI 89, 45100 Rovigo
- Address
- Via Nicolo' Giustiniani 2, 35128 Padua
- Address
- Piazza Oms 1, 24127 Bergamo
- Address
- Via Cherasco 15, 10126 Turin
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Fondazione Arianna Anticoagulazione.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.